Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Assets Average (2021 - 2023)

Historic Assets Average for Candel Therapeutics (CADL) over the last 3 years, with Q3 2023 value amounting to $54.4 million.

  • Candel Therapeutics' Assets Average fell 3899.94% to $54.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $54.4 million, marking a year-over-year decrease of 3899.94%. This contributed to the annual value of $83.4 million for FY2022, which is 3091.22% up from last year.
  • Candel Therapeutics' Assets Average amounted to $54.4 million in Q3 2023, which was down 3899.94% from $63.0 million recorded in Q2 2023.
  • In the past 5 years, Candel Therapeutics' Assets Average ranged from a high of $97.4 million in Q2 2022 and a low of $54.4 million during Q3 2023
  • Over the past 3 years, Candel Therapeutics' median Assets Average value was $81.3 million (recorded in 2022), while the average stood at $78.8 million.
  • As far as peak fluctuations go, Candel Therapeutics' Assets Average skyrocketed by 4072.8% in 2022, and later plummeted by 3899.94% in 2023.
  • Quarter analysis of 3 years shows Candel Therapeutics' Assets Average stood at $92.6 million in 2021, then fell by 12.13% to $81.3 million in 2022, then tumbled by 33.15% to $54.4 million in 2023.
  • Its last three reported values are $54.4 million in Q3 2023, $63.0 million for Q2 2023, and $72.5 million during Q1 2023.